Apyx Medical Q1 EPS $(0.10) Beats $(0.12) Estimate, Sales $9.43M Beat $9.39M Estimate
Author: Benzinga Newsdesk | May 08, 2025 06:01am
Apyx Medical (NASDAQ:
APYX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 54.55 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $9.43 million which beat the analyst consensus estimate of $9.39 million by 0.44 percent. This is a 7.95 percent decrease over sales of $10.24 million the same period last year.
Posted In: APYX